EX-23.1 3 brhc10022952_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
The Board of Directors
Immunocore Limited:
 
We consent to the use of our report incorporated by reference herein.
 
Our report refers to a change in the method of accounting for leases as of January 1, 2019, due to the adoption of IFRS 16, Leases.

/s/ KPMG LLP
 
London, United Kingdom
 
April 12, 2021